Skip to main content
Watch Insiders
MBXHealthcare

MBX Biosciences Inc. (MBX) Insider Trading

In the last 90 days, 1 MBX Biosciences Inc. (MBX) insider reported no open-market purchases and 1 sale totaling $24,335. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 4, 2026Salomon AzoulayChief Medical OfficerSale370$65.77$24,335
May 8, 2026Salomon AzoulayChief Medical OfficerSale70,003$38.36$2,685,518
May 6, 2026Salomon AzoulayChief Medical OfficerSale231$29.54$6,824
May 6, 2026P. Kent HawrylukPresident & CEOSale607$29.54$17,931

Common questions

MBX insider trading FAQ

Are MBX insiders buying or selling?
Over the last 90 days, MBX insiders were net sellers, reporting $0.00 of open-market purchases and $24,335 of sales.
When was the last MBX insider purchase?
No open-market insider purchase of MBX Biosciences Inc. stock was reported in the last 90 days.
Where does MBX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that MBX Biosciences Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.